Regulation of transcription factor Twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition
- PMID: 22241470
- PMCID: PMC3293571
- DOI: 10.1074/jbc.M111.291385
Regulation of transcription factor Twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition
Abstract
Deciphering molecular mechanisms that control epithelial-to-mesenchymal transition (EMT) contributes to our understanding of how tumor cells become invasive and competent for intravasation. We have established that transforming growth factor β activates Smad proteins, which induce expression of the embryonic factor high mobility group A2 (HMGA2), which causes mesenchymal transition. HMGA2 associates with Smad complexes and induces expression of an established regulator of EMT, the zinc finger transcription factor Snail. We now show that HMGA2 can also induce expression of a second regulator of EMT, the basic helix-loop-helix transcription factor Twist. Silencing of endogenous Twist demonstrated that this protein acts in a partially redundant manner together with Snail. Double silencing of Snail and Twist reverts mesenchymal HMGA2-expressing cells to a more epithelial phenotype when compared with single silencing of Snail or Twist. Furthermore, HMGA2 can directly associate with A:T-rich sequences and promote transcription from the Twist promoter. The new evidence proposes a model whereby HMGA2 directly induces multiple transcriptional regulators of the EMT program and, thus, is a potential biomarker for carcinomas displaying EMT during progression to more advanced stages of malignancy.
Figures
![FIGURE 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3293571/bin/zbc0111299580001.gif)
![FIGURE 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3293571/bin/zbc0111299580002.gif)
![FIGURE 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3293571/bin/zbc0111299580003.gif)
![FIGURE 4.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3293571/bin/zbc0111299580004.gif)
![FIGURE 5.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3293571/bin/zbc0111299580005.gif)
![FIGURE 6.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3293571/bin/zbc0111299580006.gif)
![FIGURE 7.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3293571/bin/zbc0111299580007.gif)
Similar articles
-
HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition.J Biol Chem. 2008 Nov 28;283(48):33437-46. doi: 10.1074/jbc.M802016200. Epub 2008 Oct 1. J Biol Chem. 2008. PMID: 18832382 Free PMC article.
-
HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.Cancer Lett. 2014 Dec 1;355(1):130-40. doi: 10.1016/j.canlet.2014.09.007. Epub 2014 Sep 11. Cancer Lett. 2014. PMID: 25218351
-
Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition.J Cell Biol. 2006 Jul 17;174(2):175-83. doi: 10.1083/jcb.200512110. Epub 2006 Jul 10. J Cell Biol. 2006. PMID: 16831886 Free PMC article.
-
The roles of HLH transcription factors in epithelial mesenchymal transition and multiple molecular mechanisms.Clin Exp Metastasis. 2014 Mar;31(3):367-77. doi: 10.1007/s10585-013-9621-6. Epub 2013 Oct 26. Clin Exp Metastasis. 2014. PMID: 24158354 Review.
-
AKT-ions with a TWIST between EMT and MET.Oncotarget. 2016 Sep 20;7(38):62767-62777. doi: 10.18632/oncotarget.11232. Oncotarget. 2016. PMID: 27623213 Free PMC article. Review.
Cited by
-
Dysregulation of TCONS_00006091 contributes to the elevated risk of oral squamous cell carcinoma by upregulating SNAI1, IRS and HMGA2.Sci Rep. 2024 Apr 26;14(1):9616. doi: 10.1038/s41598-024-60310-4. Sci Rep. 2024. PMID: 38671227 Free PMC article.
-
Gain-of-Function p53 Mutation Acts as a Genetic Switch for TGFβ Signaling-Induced Epithelial-to-Mesenchymal Transition in Intestinal Tumors.Cancer Res. 2024 Jan 2;84(1):56-68. doi: 10.1158/0008-5472.CAN-23-1490. Cancer Res. 2024. PMID: 37851521 Free PMC article.
-
Boolean modeling of mechanosensitive epithelial to mesenchymal transition and its reversal.iScience. 2023 Mar 2;26(4):106321. doi: 10.1016/j.isci.2023.106321. eCollection 2023 Apr 21. iScience. 2023. PMID: 36968076 Free PMC article.
-
METTL3-mediated m6A modification of HMGA2 mRNA promotes subretinal fibrosis and epithelial-mesenchymal transition.J Mol Cell Biol. 2023 Aug 3;15(3):mjad005. doi: 10.1093/jmcb/mjad005. J Mol Cell Biol. 2023. PMID: 36945110 Free PMC article.
-
TGF-β in developmental and fibrogenic EMTs.Semin Cancer Biol. 2022 Nov;86(Pt 2):136-145. doi: 10.1016/j.semcancer.2022.09.004. Epub 2022 Sep 29. Semin Cancer Biol. 2022. PMID: 36183999 Free PMC article. Review.
References
-
- Nguyen D. X., Bos P. D., Massagué J. (2009) Metastasis. From dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274–284 - PubMed
-
- Thiery J. P., Acloque H., Huang R. Y., Nieto M. A. (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139, 871–890 - PubMed
-
- Peinado H., Olmeda D., Cano A. (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 7, 415–428 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials